Glaucoma is a group of eye diseases that damage the optic nerve, which carries visual information from the eye to the brain. It is called the silent thief of sight because it typically progresses slowly without any noticeable symptoms in its early stages. By the time vision loss becomes apparent, significant and irreversible damage has already occurred. Regular eye examinations are the only way to detect glaucoma early, before vision is permanently lost. In India, an estimated 90% of glaucoma cases remain undiagnosed.

Glaucoma is primarily caused by increased pressure inside the eye (intraocular pressure or IOP), which damages the optic nerve over time. This pressure builds up when the eye’s drainage system (trabecular meshwork) becomes clogged or blocked, preventing the clear fluid (aqueous humor) from draining properly. Other risk factors include advancing age (over 40), family history of glaucoma, diabetes, high myopia (nearsightedness), long-term steroid use, eye injuries, and certain ethnic backgrounds (African, Asian descent). Some people develop glaucoma even with normal eye pressure (normal-tension glaucoma).

The main types of glaucoma are: (1) Primary Open-Angle Glaucoma (POAG) – the most common form where the drainage angle remains open but the trabecular meshwork becomes less efficient over time. (2) Angle-Closure Glaucoma – occurs when the iris blocks the drainage angle, causing sudden pressure spikes. This can be acute (emergency) or chronic. (3) Congenital Glaucoma – a rare form present at birth due to abnormal drainage system development. (4) Secondary Glaucoma – caused by other conditions like eye injury, diabetes, uveitis, steroid use, or cataracts. (5) Normal-Tension Glaucoma – optic nerve damage occurs despite normal eye pressure.

Glaucoma diagnosis involves several specialized tests: (1) Tonometry – measures intraocular pressure (IOP). (2) OCT RNFL (Optical Coherence Tomography of Retinal Nerve Fiber Layer) – detects thinning of nerve fibers before vision loss occurs. (3) Visual Field Test (Perimetry) – maps peripheral vision to detect blind spots. (4) Gonioscopy – examines the drainage angle. (5) Pachymetry – measures corneal thickness which affects IOP readings. (6) Optic Disc Photography – documents optic nerve appearance for comparison over time. At Crystal Clear Eye and Topax Eye Care, Dr. Jignesh Gala uses advanced diagnostic technology for early and accurate detection. A comprehensive glaucoma screening takes about 45-60 minutes.

Glaucoma surgery costs in Mumbai vary by procedure: SLT Laser Trabeculoplasty costs Rs. 8,000-15,000 per session. YAG Laser Iridotomy costs Rs. 5,000-10,000. Trabeculectomy (gold standard surgery) costs Rs. 25,000-40,000. Glaucoma Drainage Device/Tube Shunt (Ahmed, Baerveldt) costs Rs. 35,000-60,000. MIGS procedures like iStent cost Rs. 30,000-50,000. Combined Cataract + Glaucoma surgery costs Rs. 40,000-70,000. Diagnostic tests range from Rs. 3,500-5,500 for a comprehensive screening package. Most procedures are covered by health insurance. Cashless facility is available at Crystal Clear Eye and Topax Eye Care.

Yes, glaucoma treatment and surgery are covered by most health insurance plans in India as glaucoma is a medical necessity, not a cosmetic procedure. Coverage typically includes diagnostic tests, medications, laser treatments (SLT, YAG), and surgical procedures (trabeculectomy, tube shunt). Some insurers may have specific limits on laser sessions per year. Major insurance providers covering glaucoma treatment include Star Health, ICICI Lombard, Bajaj Allianz, HDFC Ergo, New India Assurance, United India, and PSU insurance. Cashless facility is available at Crystal Clear Eye and Topax Eye Care. Call 077188 85245 to verify your specific coverage.

SLT (Selective Laser Trabeculoplasty) is a non-invasive laser procedure used to treat open-angle glaucoma. It uses low-energy laser pulses to stimulate the trabecular meshwork (the eye’s drainage system), improving fluid outflow and reducing intraocular pressure. SLT is safe, painless, performed in the clinic without anesthesia, takes only 10-15 minutes, and has minimal side effects. It can be repeated if needed and may reduce or eliminate the need for eye drops. Effectiveness is 70-80% with IOP reduction of 20-30%. Cost ranges from Rs. 8,000-15,000 per session and is often covered by insurance.

Trabeculectomy is the gold standard surgical procedure for glaucoma. It involves creating a new drainage channel (a tiny flap) in the sclera (white of the eye) to allow aqueous humor to bypass the blocked drainage system and flow out, reducing intraocular pressure. A small bubble called a bleb forms under the upper eyelid where the fluid collects before being absorbed by surrounding tissue. The surgery takes 45-60 minutes under local anesthesia and is performed on an outpatient basis. Success rate is 80-90% at 1 year with IOP reduction of 30-50%. Cost ranges from Rs. 25,000-40,000 and is covered by most insurance plans.

A glaucoma drainage device (tube shunt) is an implant placed in the eye to create an alternative drainage pathway for aqueous humor. Common devices include the Ahmed Glaucoma Valve, Baerveldt Implant, and Molteno implant. A small tube is inserted into the anterior chamber, and a plate is secured to the sclera under the conjunctiva. The device drains excess fluid to a reservoir, lowering IOP. It is used when trabeculectomy has failed or for complex glaucoma cases (neovascular, uveitic, congenital). Surgery takes 1-2 hours. Cost ranges from Rs. 35,000-60,000. Most insurance plans cover this procedure.

MIGS refers to a group of micro-invasive surgical procedures designed to lower IOP with minimal tissue disruption and faster recovery. Popular MIGS procedures include iStent (a tiny titanium stent placed in the trabecular meshwork), Hydrus Microstent, Xen Gel Stent, and Gonioscopy-Assisted Transluminal Trabeculotomy (GATT). MIGS is ideal for early-to-moderate glaucoma, often combined with cataract surgery. Advantages include tiny incisions, quick recovery (days vs weeks), high safety profile, and reduced medication dependence. However, IOP reduction is more modest compared to trabeculectomy. Cost ranges from Rs. 30,000-50,000.

Currently, there is no cure for glaucoma. Vision loss from glaucoma is irreversible. However, glaucoma can be effectively managed to slow or halt disease progression and preserve remaining vision. Treatment options include eye drops, oral medications, laser therapy (SLT, YAG), and surgery (trabeculectomy, tube shunt, MIGS). The key is early detection through regular screening and strict adherence to treatment. Lifelong follow-up care is essential. With proper management, most glaucoma patients maintain useful vision throughout their lives. Research into neuroprotective therapies and stem cell treatments is ongoing.

Common glaucoma eye drops include: (1) Prostaglandin analogs (Latanoprost, Bimatoprost, Travoprost) – increase fluid outflow, usually the first choice, once daily. (2) Beta-blockers (Timolol, Betaxolol) – reduce fluid production, once or twice daily. (3) Alpha-agonists (Brimonidine) – reduce production and increase outflow, 2-3 times daily. (4) Carbonic anhydrase inhibitors (Dorzolamide, Brinzolamide) – reduce production, 2-3 times daily. (5) Rho kinase inhibitors (Netarsudil) – increase outflow. (6) Combination drops (combining two medications for convenience). All eye drops require daily use and have potential side effects. Your doctor will prescribe the most suitable option based on your glaucoma type, severity, and medical history.

Recovery after glaucoma surgery varies by procedure. SLT Laser: Immediate return to normal activities. YAG Laser Iridotomy: Same day recovery. Trabeculectomy: 1-2 weeks for initial recovery, 4-6 weeks for full healing. Vision may be blurry for the first few weeks. Multiple follow-up visits are needed to monitor the bleb and adjust eye drops. Tube Shunt: 2-3 weeks for initial recovery. MIGS (iStent): 1-3 days recovery since it is often combined with cataract surgery. During recovery, avoid rubbing the eye, strenuous activity, swimming, and dusty environments. Use all prescribed eye drops as directed. Full visual stabilization may take 6-12 weeks.

Glaucoma patients require lifelong monitoring. Newly diagnosed patients on medication: every 3-4 months. Stable patients: every 4-6 months. Post-SLT: 1-2 weeks, then 6-8 weeks, then every 3-4 months. Post-trabeculectomy: day 1, week 1, week 2, month 1, month 3, then every 3-4 months. Each visit typically includes IOP measurement, visual field testing (every 6-12 months), OCT RNFL (every 6-12 months), and optic disc examination. Regular follow-up is critical to detect progression and adjust treatment. Never skip appointments even if your vision feels fine – glaucoma progression is silent.

Open-angle glaucoma typically has NO symptoms in early stages – this is why regular screening is essential. As the disease progresses, patients may notice gradual loss of peripheral (side) vision, often described as tunnel vision. Acute angle-closure glaucoma is an emergency with sudden symptoms: severe eye pain, headache, blurred vision, halos around lights, nausea and vomiting, and a red eye. If you experience these acute symptoms, seek emergency care immediately. Congenital glaucoma in infants may cause enlarged eyes, excessive tearing, light sensitivity, and cloudiness of the cornea. Any sudden change in vision requires urgent evaluation.

Normal intraocular pressure (IOP) ranges from 10 to 21 mmHg, with an average of about 15-16 mmHg. IOP above 21 mmHg is generally considered elevated (ocular hypertension), but glaucoma can occur even at normal pressures (normal-tension glaucoma). Conversely, some people may have higher-than-normal IOP without optic nerve damage (ocular hypertension without glaucoma). Target IOP for glaucoma patients is individualized based on disease severity – typically 30-50% below baseline. IOP also fluctuates throughout the day (diurnal variation), so multiple measurements may be needed for accurate assessment.

Risk factors for glaucoma include: Age over 40 (risk increases with age), family history of glaucoma (especially siblings), African, Asian, or Hispanic ethnicity, high myopia (severe nearsightedness), diabetes, hypertension, long-term corticosteroid use (eye drops, inhalers, oral), previous eye injury or surgery, thin corneas (measured by pachymetry), and certain medical conditions like sleep apnea. If you have any of these risk factors, annual comprehensive eye examinations with glaucoma screening are strongly recommended. Early detection saves vision.

Yes, congenital glaucoma (also called infantile or pediatric glaucoma) is a rare but serious condition present at birth or developing in early childhood. It occurs due to abnormal development of the eye’s drainage system. Signs include enlarged or cloudy corneas, excessive tearing, light sensitivity (photophobia), and eyelid spasms. Congenital glaucoma requires surgical treatment – usually goniotomy or trabeculotomy, which have 70-90% success rates when performed early. Dr. Jignesh Gala provides specialized pediatric glaucoma evaluation and surgery. If you notice these symptoms in your child, seek evaluation immediately at Crystal Clear Eye.

While lifestyle changes cannot cure glaucoma, they can support treatment: (1) Take ALL prescribed eye drops exactly as directed – missed doses can accelerate damage. (2) Regular exercise like walking may modestly lower IOP. (3) Avoid head-down positions (certain yoga poses) which can increase IOP. (4) Limit caffeine intake as it may transiently raise IOP. (5) Stay hydrated but avoid drinking large amounts of fluid at once. (6) Protect eyes from injury with safety glasses. (7) Maintain a healthy diet rich in antioxidants. (8) Manage blood pressure and diabetes. (9) Avoid smoking. (10) Never stop or change glaucoma medication without consulting your doctor.

Dr. Jignesh Gala is a triple board-certified ophthalmic surgeon (FRCS Glasgow, MRCS Edinburgh, FICO London) with 12+ years of experience, 25,780+ surgeries, and 162,000+ patients treated. He offers comprehensive glaucoma care including medical management, SLT/YAG laser treatments, trabeculectomy, tube shunt implants, and MIGS procedures at Crystal Clear Eye and Topax Eye Care. Both centres feature state-of-the-art diagnostic equipment including OCT, visual field analyzers, pachymeters, and gonioscopy lenses. Cashless insurance facility is available. Dr. Gala’s approach combines the latest evidence-based treatments with personalized care plans for each patient. His expertise spans from routine glaucoma screening to complex surgical cases. Book your glaucoma screening at 077188 85245.